Secondary Logo

Journal Logo

Most Popular Articles

Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study

Vija Racaru, Lavinia; Sinigaglia, Mathieu; Kanoun, Salim; More

Nuclear Medicine Communications. 39(7):672-679, July 2018.

Hypoxia imaging with [18F]HX4 PET in squamous cell head and neck cancers: a pilot study for integration into treatment planning

Betts, Helen M.; O’Connor, Richard A.; Christian, Judith A.; More

Nuclear Medicine Communications. 40(1):73-78, January 2019.

Time trend analysis of pulmonary embolism diagnosis with single-photon emission computed tomography ventilation/perfusion imaging

Truffault, Blandine; Robin, Philippe; Tromeur, Cecile; More

Nuclear Medicine Communications. 40(6):576-582, June 2019.

Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma

Huang, Honghui; Xiao, Fei; Han, Xiaofeng; More

Nuclear Medicine Communications. 37(7):689-698, July 2016.

The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes

Uyama, Naoto; Otsuka, Hideki; Shinya, Takayoshi; More

Nuclear Medicine Communications. 38(6):487-492, June 2017.

Significance of the preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the future remnant liver: a sequential study of regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the whole liver

Tanoue, Yukinori; Nanashima, Atsushi; Yano, Koichi; More

Nuclear Medicine Communications. 40(2):145-152, February 2019.

Cost-effectiveness of second-line diagnostic investigations in patients included in the DANTE trial: a randomized controlled trial of lung cancer screening with low-dose computed tomography

Lopci, Egesta; Castello, Angelo; Morenghi, Emanuela; More

Nuclear Medicine Communications. 40(5):508-516, May 2019.

Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction?

Voltin, Conrad-Amadeus; Mettler, Jasmin; Boellaard, Ronald; More

Nuclear Medicine Communications. 40(3):249-257, March 2019.

2015 UK software audit of hepatobiliary scintigraphy

O’Shaughnessy, Emma R.; Murray, Anthony; Taylor, Jonathan C.; More

Nuclear Medicine Communications. 40(2):136-144, February 2019.

Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMI

Seraj, Siavash Mehdizadeh; Al-Zaghal, Abdullah; Zadeh, Mahdi Z.; More

Nuclear Medicine Communications. 40(5):545-551, May 2019.

Adenosine single-photon emission computed tomography-derived transient ischemic dilatation and ejection fraction reserve fail to predict multivessel coronary artery disease

Driessen, Roel S.; Raijmakers, Pieter G.; Danad, Ibrahim; More

Nuclear Medicine Communications. 40(7):773-774, July 2019.

Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma

Sager, Sait; Akgün, Elife; Uslu-Besli, Lebriz; More

Nuclear Medicine Communications. 40(5):461-468, May 2019.

Correlation between tumour biology status measured in triple-tracer 18F-fluorodeoxyglucose–18F-fluorothymidine– 18F-fluoromisonidazole-PET/CT study and human papillomavirus status in patients with head and neck cancer

Cegla, Paulina; Joanna, Kazmierska; Sebastian, Gwozdz; More

Nuclear Medicine Communications. 40(7):752-757, July 2019.

Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy

Rice, Stephanie R.; Saboury, Babak; Houshmand, Sina; More

Nuclear Medicine Communications. 40(6):618-625, June 2019.

Show: